ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
59052 | CD28_MOUSE | P31041; Q6GSH7 | Cd28 | T-cell-specific surface glycoprotein CD28; CD28 | 12487 |
59051 | CD28_HUMAN | A8KAC1; P10747; Q13964; Q52M23; Q70WG0; Q8NI54; Q8NI55; Q8NI56; Q8WXJ2 | CD28 | T-cell-specific surface glycoprotein CD28; TP44; CD28 | 940 |
59050 | CD28_FELCA | O02757 | CD28 | T-cell-specific surface glycoprotein CD28; CD28 | 0 |
59049 | CD28_CHICK | P31043 | CD28 | T-cell-specific surface glycoprotein CD28 homolog; CHT28 | 396249 |
59048 | CD28_BOVIN | Q28071 | CD28 | T-cell-specific surface glycoprotein CD28; CD28 | 281050 |
59047 | CD27_MOUSE | P41272 | Cd27 | CD27 antigen; CD27L receptor; T-cell activation antigen CD27; Tumor necrosis factor receptor superfamily member 7; CD27 | 21940 |
59046 | CD27_HUMAN | B2RDZ0; P26842 | CD27 | CD27 antigen; CD27L receptor; T-cell activation antigen CD27; T14; Tumor necrosis factor receptor superfamily member 7; CD27 | 939 |
59045 | CD27B_ARATH | Q8LGU6; Q8W4M8; Q9SL81 | CDC27B | Cell division cycle protein 27 homolog B; CDC27 homolog B; Protein HOBBIT | 816519 |
59044 | CD27A_ARATH | O04325; Q06AN9; Q9LU16 | CDC27A | Cell division cycle protein 27 homolog A; CDC27 homolog A; Anaphase-promoting complex subunit 3 | 820879 |
59043 | CD276_XENLA | Q68EV1 | cd276 | CD276 antigen homolog; CD276 | 447379 |
59042 | CD276_RAT | Q7TPB4 | Cd276 | CD276 antigen; B7 homolog 3; B7-H3; Costimulatory molecule; CD276 | 315716 |
59041 | CD276_MOUSE | Q8VE98 | Cd276 | CD276 antigen; B7 homolog 3; B7-H3; Costimulatory molecule; CD276 | 102657 |
59040 | CD276_HUMAN | Q5ZPR3; Q6P5Y4; Q6UXI2; Q8NBI8; Q8NC34; Q8NCB6; Q9BXR1 | CD276 | CD276 antigen; 4Ig-B7-H3; B7 homolog 3; B7-H3; Costimulatory molecule; CD276 | 80381 |
59039 | CD24_RAT | Q07490; Q0P5T1 | Cd24 | Signal transducer CD24; Heat-stable antigen; HSA; Nectadrin; CD24 | 25145 |
59038 | CD24_MOUSE | P24807; P26691 | Cd24 | Signal transducer CD24; Lymphocyte antigen 52; Ly-52; M1/69-J11D heat stable antigen; HSA; Nectadrin; R13-Ag; X62 heat stable antigen; CD24 | 12484 |
59037 | CD24_HUMAN | A0A087WYI6; B6EC88; P25063; Q16257; Q53XS0; R4I4T5 | CD24 | Signal transducer CD24; Small cell lung carcinoma cluster 4 antigen; CD24 | 100133941 |
59036 | CD248_MOUSE | Q3UMV6; Q91V98; Q91ZV1 | Cd248 | Endosialin; Tumor endothelial marker 1; CD248 | 70445 |
59035 | CD248_HUMAN | Q2M2V5; Q3SX55; Q96KB6; Q9HCU0 | CD248 | Endosialin; Tumor endothelial marker 1; CD248 | 57124 |
59034 | CD244_RAT | Q9JLM2; Q9JLM3 | Cd244 | Natural killer cell receptor 2B4; NK cell type I receptor protein 2B4; NKR2B4; Non-MHC restricted killing associated; CD244 | 64025 |
59033 | CD244_MOUSE | O88654; Q07763; Q3UV86; Q9JIE0 | Cd244 | Natural killer cell receptor 2B4; NK cell type I receptor protein 2B4; NKR2B4; Non-MHC restricted killing associated; SLAM family member 4; SLAMF4; Signaling lymphocytic activation molecule 4; CD244 | 18106 |
59032 | CD244_HUMAN | Q5VYI2; Q5VYI6; Q5VYI7; Q96T47; Q9BZW8; Q9NQD2; Q9NQD3; Q9Y288 | CD244 | Natural killer cell receptor 2B4; NK cell activation-inducing ligand; NAIL; NK cell type I receptor protein 2B4; NKR2B4; h2B4; SLAM family member 4; SLAMF4; Signaling lymphocytic activation molecule 4; CD244 | 51744 |
59031 | CD22_PONPY | Q9N1E3 | CD22 {ECO:0000250|UniProtKB:P20273} | B-cell receptor CD22 {ECO:0000250|UniProtKB:P20273}; Sialic acid-binding Ig-like lectin 2; Siglec-2; CD22 | 0 |
59030 | CD22_PANTR | A0A6D2WBT6; Q9N1E6 | CD22 {ECO:0000250|UniProtKB:P20273} | B-cell receptor CD22 {ECO:0000250|UniProtKB:P20273}; Sialic acid-binding Ig-like lectin 2; Siglec-2; CD22 | 450167 |
59029 | CD22_PANPA | A0A2R9BGU9; Q9N1E5 | CD22 {ECO:0000250|UniProtKB:P20273} | B-cell receptor CD22 {ECO:0000250|UniProtKB:P20273}; Sialic acid-binding Ig-like lectin 2; Siglec-2; CD22 | 0 |
59028 | CD22_MOUSE | P35329; Q3UP36; Q9JHL2; Q9JJX9; Q9JJY0; Q9JJY1; Q9R056; Q9R094; Q9WU51 | Cd22 {ECO:0000303|PubMed:10501843, ECO:0000312|MGI:MGI:88322} | B-cell receptor CD22 {ECO:0000305}; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD22 | 12483 |
59027 | CD22_HUMAN | F5GYU4; F5H7U3; O95699; O95701; O95702; O95703; P20273; Q01665; Q32M46 | CD22 {ECO:0000303|PubMed:1691828, ECO:0000312|HGNC:HGNC:1643} | B-cell receptor CD22 {ECO:0000305}; B-lymphocyte cell adhesion molecule; BL-CAM; Sialic acid-binding Ig-like lectin 2; Siglec-2; T-cell surface antigen Leu-14; CD22 | 933 |
59026 | CD22_GORGO | G3R153; Q9N1E4 | CD22 {ECO:0000250|UniProtKB:P20273} | B-cell receptor CD22 {ECO:0000250|UniProtKB:P20273}; Sialic acid-binding Ig-like lectin 2; Siglec-2; CD22 | 101140765 |
59025 | CD226_MOUSE | Q8K4F0 | Cd226 | CD226 antigen; Platelet and T-cell activation antigen 1; CD226 | 225825 |
59024 | CD226_MACMU | O18906 | CD226 | CD226 antigen; Platelet and T-cell activation antigen 1; CD226 | 703878 |
59023 | CD226_HUMAN | B2R818; Q15762 | CD226 | CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD226 | 10666 |
59022 | CD20_MOUSE | P19437 | Ms4a1 | B-lymphocyte antigen CD20; B-cell differentiation antigen Ly-44; Lymphocyte antigen 44; Membrane-spanning 4-domains subfamily A member 1; CD20 | 12482 |
59021 | CD20_HUMAN | A6NMS4; B4DT24; P08984; P11836; Q13963 | MS4A1 | B-lymphocyte antigen CD20; B-lymphocyte surface antigen B1; Bp35; Leukocyte surface antigen Leu-16; Membrane-spanning 4-domains subfamily A member 1; CD20 | 931 |
59020 | CD20_CANLF | Q3C2E2 | MS4A1 | B-lymphocyte antigen CD20; Membrane-spanning 4-domains subfamily A member 1; CD20 | 485430 |
59019 | CD20B_HUMAN | B7WNV8; B9EGL8; C9J6X8; C9JHE9; C9JKL5; Q86Y31; Q86Y32; Q86Y33; Q8IUZ8 | CDC20B | Cell division cycle protein 20 homolog B | 166979 |
59018 | CD209_SYMSY | Q8HY02 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59017 | CD209_PONPY | Q8HXZ9; Q8HY00 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59016 | CD209_PAPHA | Q8HY04 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59015 | CD209_PANTR | Q8HXZ7; Q8HYB9; Q95L98 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 450160 |
59014 | CD209_NOMCO | Q8HY01 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59013 | CD209_MACNE | Q95LC6 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 105484282 |
59012 | CD209_MACMU | Q8HXL6; Q8HXL7; Q8HXL8; Q8HXL9; Q8SQB2; Q95J96; Q95LA8 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 574211 |
59011 | CD209_HYLLA | Q8HY03 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59010 | CD209_HUMAN | A8KAM4; A8MVQ9; G5E9C4; Q2TB19; Q96QP7; Q96QP8; Q96QP9; Q96QQ0; Q9NNX6 | CD209 | CD209 antigen; C-type lectin domain family 4 member L; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN; DC-SIGN1; CD209 | 30835 |
59009 | CD209_GORGO | Q8HXZ8 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59008 | CD209_CHLAE | P60883 | CD209 | CD209 antigen; Dendritic cell-specific ICAM-3-grabbing non-integrin 1; DC-SIGN1; CD209 | 0 |
59007 | CD205_ARATH | Q3E906 | CDC20-5 | Cell division cycle 20.5, cofactor of APC complex; AtCDC20.5 | 832817 |
59006 | CD203_ARATH | F4K2T7; Q9S7H3 | CDC20-3 | Cell division cycle 20.3, cofactor of APC complex; AtCDC20.3 | 832766 |
59005 | CD1E_HUMAN | B4DZV3; E7EP01; P15812; Q5TDJ9; Q5TDK3; Q5TDK4; Q5TDK5; Q5TDK6; Q5TDK8; Q712F2; Q712F3; Q712F4; Q712F5; Q96TD0; Q96TD1; Q9UMM1; Q9Y5M3 | CD1E | T-cell surface glycoprotein CD1e, membrane-associated; hCD1e; R2G1; CD1e; sCD1e | 913 |
59004 | CD1E_CAVPO | Q9QZY5 | CD1E | T-cell surface glycoprotein CD1e, membrane-associated; mCD1e; CD1e; sCD1e | 100379271 |
59003 | CD1D_SYLFL | P23043 | CD1D | Antigen-presenting glycoprotein CD1d; Leukocyte differentiation-like antigen Ta; CD1d | 0 |